Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy

European Respiratory Journal

Volumn 27, Issue 5, 2006, Pages 1033-1039

  Wewel, A R ^a   Crusius, J A M ^a   Gatzemeier, U ^a   Heckmayr, M ^a   Becher, G ^b   Magnussen, H ^a   Jorrens R A ^a,c   Holz, O ^a,d  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b FILT GmbH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d LEUPHANA UNIVERSITY OF LÜNEBURG   (Germany)

Author keywords

Carboplatin; Cisplatin; Exhaled breath condensate; Neutrophils; Peripheral blood

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DEXAMETHASONE; HYDROGEN PEROXIDE; NITRIC OXIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; AIRWAY CONDUCTANCE; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOPENIA; LUNG CANCER; MALE; MONOCYTE; MULTIPLE CYCLE TREATMENT; NEUTROPHIL COUNT; PREDICTION; PRIORITY JOURNAL; TREATMENT DURATION; VOMITING;

EXHALATION; FEMALE; HUMANS; HYDROGEN PEROXIDE; LEUKOCYTE COUNT; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUTROPHILS; NITRIC OXIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TIME FACTORS;

EID: 33845502489     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00101705     Document Type: Article

References (35)

1. van Beurden WJ, Dekhuijzen PN. Hydrogen peroxide in exhaled breath condensate. In: Paolo Montusci, ed. New Perspectives in Monitoring Lung Inflammation. Analysis of Exhaled Breath Condensate. Boca Raton, London, New York, Washington DC, CRC Press, 2005; pp. 67-72.
2. Dekhuijzen PN, Aben KK, Dekker I, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 813-816.
3. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999; 93: 389-396.
4. De Benedetto F, Aceto A, Dragani B, et al. Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients. Monaldi Arch Chest Dis 2000; 55: 185-188.
5. Loukides S, Bouros D, Papatheodorou G, Lachanis S, Panagou P, Siafakas NM. Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 2002; 121: 81-87.
6. Antczak A, Nowak D, Shariati B, Krol M, Piasecka G, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997; 10: 1235-1241.
7. Jöbsis Q, Raatgeep HC, Hermans PW, de Jongste JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997; 10: 519-521.
8. Horvath I, Donnelly LE, Kiss A, et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998; 158: 1042-1046.
9. Emelyanov A, Fedoseev G, Abulimity A, et al. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 2001; 120: 1136-1139.
10. Majewska E, Kasielski M, Luczyski R, Bartosz G, Bialasiewicz P, Nowak D. Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia. Respir Med 2004; 98: 669-676.
11. Jöbsis Q, Raatgeep HC, Schellekens SL, Kroesbergen A, Hop WC, de Jongste JC. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 2000; 16: 95-100.
12. Antczak A, Kurmanowska Z, Kasielski M, Nowak D. Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients. Respir Med 2000; 94: 416-421.
13. Emelyanov A, Fedoseev G, Krasnoschekova O, Abulimity A, Trendeleva T, Barnes PJ. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002; 20: 596-600.
14. van Beurden WJ, Harff GA, Dekhuijzen PN, van der Poel-Smet SM, Smeenk FW. Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration 2003; 70: 242-248.
15. Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001; 95: 448-456.
16. De Benedetto F, Aceto A, Dragani B, et al. Long-term oral N-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. Pulm Pharmacol Ther 2005; 18: 41-47.
17. Schleiss MB, Holz O, Behnke M, Richter K, Magnussen H, Jörres RA. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000; 16: 1115-1118.
18. Antczak A, Nowak D, Bialasiewicz P, Kasielski M. Hydrogen peroxide in expired air condensate correlates positively with early steps of peripheral neutrophil activation in asthmatic patients. Arch Immunol Ther Exp (Warsz) 1999; 47: 119-126.
19. Szkudlarek U, Maria L, Kasielski M, Kaucka S, Nowak D. Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects. Respir Med 2003; 97: 718-725.
20. National Heart, Lung and Blood Institute/World Health Organization. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276. For an update of definitions (2004) see www.goldcopd.com. Date last updated: September 2005. Date last accessed: February 28,2006.
21. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
22. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999. Am J Respir Crit Care Med 1999; 160: 2104-2117.
23. Ichinose M, Sugiura H, Yamagata S, et al. Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD) airways. Eur Respir J 2003; 22: 457-461.
24. Latzin P, Griese M. Exhaled hydrogen peroxide, nitrite and nitric oxide in healthy children: decrease of hydrogen peroxide by atmospheric nitric oxide. Eur J Med Res 2002; 7: 353-358.
25. Domagala-Kulawik J, Guzman J, Costabel U. Immune cells in bronchoalveolar lavage in peripheral lung cancer - analysis of 140 cases. Respiration 2003; 70: 43-48.
26. Beeh KM, Beier J, Ernst M, Kommann O, Buhl R. Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer. Respiration 2003; 70: 166-171.
27. Hara N, Ichinose Y, Motohiro A, Kuda T, Aso H, Ohta M. Influence of chemotherapeutic agents on superoxide anion production by human polymorphonuclear leukocytes. Cancer 1990; 66: 684-688.
28. Somani S, Husain K, Whitworth C, Trammell G, Malafa M, Rybak L. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol 2000; 86: 234-241.
29. Palma JP, Aggarwal SK. Cisplatin and carboplatin mediated release of cytolytic factors in murine peritoneal macrophages in vitro. Anticancer Drugs 1994; 5: 615-622.
30. Son K, Kim YM. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing. Cancer Res 1995; 55: 5524-5527.
31. Ranjan P, Sodhi A, Singh SM. Murine peritoneal macrophages treated with cisplatin and interferon-gamma undergo NO-mediated apoptosis via activation of an endonuclease. Anticancer Drugs 1998; 9: 333-341.
32. Högman M, Holmkvist T, Walinder R, et al. Increased nitric oxide elimination from the airways after smoking cessation. Clin Sci (Lond) 2002; 103: 15-19.
33. Hilbert J, Mohsenin V. Adaptation of lung antioxidants to cigarette smoking in humans. Chest 1996; 110: 916-920.
34. van Beurden WJ, Dekhuijzen PN, Harff GA, Smeenk FW. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration 2002; 69: 211-216.
35. Van Hoydonck PG, Wuyts WA, Vanaudenaerde BM, Schouten EG, Dupont LJ, Temme EH. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 2004; 23: 189-192.